SNP rs2073618 of the Osteoprotegerin Gene Is Associated with Diabetic Retinopathy in Slovenian Patients with Type 2 Diabetes
Open Access
- 20 October 2013
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2013, 1-6
Abstract
Recent studies indicate that osteoprotegerin (OPG) acts as an important regulatory molecule in the vasculature. Also, a strong association was observed between circulation OPG and microvascular complication. By considering the possible role of OPG in diabetic retinopathy (DR) we examined two of the most studied polymorphisms of the OPG genes rs2073618 (located in exon I) and rs3134069 (located in the promoter region) and their relation to DR in Slovenian patients with type 2 diabetes. Logistic regression analysis demonstrated that the carriers of the CC genotype had a 2.2 higher risk for DR than those with either the CG genotype or the GG genotype (codominant model for rs2073618). Furthermore, the combined effect of single nucleotide polymorphisms (SNPs) rs2073618 and rs3134069 on the DR was stronger than that of each SNP alone. The odds ratio (OR) for individuals with CC genotype (rs2073618) and AA genotype (rs3134069) compared with carriers of CG/GG (rs2073618) + AA (rs3134069) was 2.54 (95% CI = 1.26–5.13, ). To conclude, these results indicate that SNPs in the OPG gene may be implicated in the pathogenesis of DR.Keywords
This publication has 36 references indexed in Scilit:
- Two polymorphisms (rs699947, rs2010963) in the VEGFA gene and diabetic retinopathy: an updated meta-analysisBMC Ophthalmology, 2013
- Association between TNFRSF11B gene polymorphisms and history of ischemic stroke in Italian diabetic patientsHuman Genetics, 2012
- The case for intraocular delivery of PPAR agonists in the treatment of diabetic retinopathyBMC Ophthalmology, 2012
- Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathyMetabolism, 2011
- Biomarkers of the Osteoprotegerin PathwayArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Acute hyperinsulinemia decreases plasma osteoprotegerin with diminished effect in type 2 diabetes and obesityEuropean Journal of Endocrinology, 2009
- Association Between Osteoprotegerin G1181C and T245G Polymorphisms and Diabetic Charcot NeuroarthropathyDiabetes Care, 2009
- Osteoprotegerin, vascular calcification and atherosclerosisAtherosclerosis, 2009
- An Increased Osteoprotegerin Serum Release Characterizes the Early Onset of Diabetes Mellitus and May Contribute to Endothelial Cell DysfunctionThe American Journal of Pathology, 2006
- Elevated Serum Osteoprotegerin Levels Are Associated With Vascular Endothelial Dysfunction in Type 2 DiabetesDiabetes Care, 2006